These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 18977106

  • 21. On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities.
    Liu DQ, Wu L, Sun M, MacGregor PA.
    J Pharm Biomed Anal; 2007 Jun 28; 44(2):320-9. PubMed ID: 17317074
    [Abstract] [Full Text] [Related]

  • 22. The application of gas chromatography/atmospheric pressure chemical ionisation time-of-flight mass spectrometry to impurity identification in Pharmaceutical Development.
    Bristow T, Harrison M, Sims M.
    Rapid Commun Mass Spectrom; 2010 Jun 15; 24(11):1673-81. PubMed ID: 20486265
    [Abstract] [Full Text] [Related]

  • 23. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S, Chandra Joshi S, Vir D, Agarwal A, Rao RD, Sridhar I, Xavier CM, Mathela CS.
    J Pharm Biomed Anal; 2012 Apr 07; 63():112-9. PubMed ID: 22361658
    [Abstract] [Full Text] [Related]

  • 24. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
    Ramulu K, Kumar TT, Krishna SR, Vasudev R, Kaviraj M, Rao BM, Rao NS.
    Pharmazie; 2010 Mar 07; 65(3):162-8. PubMed ID: 20383934
    [Abstract] [Full Text] [Related]

  • 25. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
    Pan C, Harmon F, Toscano K, Liu F, Vivilecchia R.
    J Pharm Biomed Anal; 2008 Feb 13; 46(3):520-7. PubMed ID: 18180126
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionisation mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry.
    Wolff JC, Thomson LA, Eckers C.
    Rapid Commun Mass Spectrom; 2003 Feb 13; 17(3):215-21. PubMed ID: 12539187
    [Abstract] [Full Text] [Related]

  • 28. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L, Mao B, Reamer R, Novak T, Ge Z.
    J Pharm Biomed Anal; 2007 Jun 28; 44(2):421-9. PubMed ID: 17142001
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of a process impurity formed during synthesis of a nevirapine analogue HIV NNRT inhibitor using LC/MS and forced degradation studies.
    Qiu F, Pennino S, Busacca CA, Norwood DL.
    J Pharm Biomed Anal; 2009 Apr 05; 49(3):733-8. PubMed ID: 19201127
    [Abstract] [Full Text] [Related]

  • 31. Use of hyphenated LC-MS/MS technique for characterization of impurity profile of quetiapine during drug development.
    Stolarczyk EU, Kutner A.
    Acta Pol Pharm; 2010 Apr 05; 67(6):599-608. PubMed ID: 21229874
    [Abstract] [Full Text] [Related]

  • 32. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B, Sharma BA, Mahale G, Singh D, Kumar A.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):256-63. PubMed ID: 21664089
    [Abstract] [Full Text] [Related]

  • 33. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y, Brill GM, Benz NJ, Leanna MR, Dhaon MK, Rasmussen M, Zhou CC, Bruzek JA, Bellettini JR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):106-17. PubMed ID: 17826364
    [Abstract] [Full Text] [Related]

  • 34. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S, Mathela CS, Agarwal A, Paul SK.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):423-8. PubMed ID: 21676571
    [Abstract] [Full Text] [Related]

  • 35. Enhanced monitoring of biopharmaceutical product purity using liquid chromatography-mass spectrometry.
    Laursen K, Justesen U, Rasmussen MA.
    J Chromatogr A; 2011 Jul 15; 1218(28):4340-8. PubMed ID: 21621780
    [Abstract] [Full Text] [Related]

  • 36. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M, Cindrić M, Koruznjak JD.
    J Pharm Biomed Anal; 2005 Apr 01; 37(4):715-21. PubMed ID: 15797793
    [Abstract] [Full Text] [Related]

  • 37. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n).
    Thomas S, Paul SK, Shandilya S, Agarwal A, Saxena N, Awasthi AK, Matta Hb, Vir D, Mathela CS.
    Analyst; 2012 Aug 07; 137(15):3571-82. PubMed ID: 22733388
    [Abstract] [Full Text] [Related]

  • 38. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG, Ghugare PD, Karmuse P, Singh D, Jadhav A, Kumar A.
    J Pharm Biomed Anal; 2009 May 01; 49(4):873-9. PubMed ID: 19201565
    [Abstract] [Full Text] [Related]

  • 39. A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents.
    Chen Q, Zielinski D, Chen J, Koski A, Werst D, Nowak S.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):732-8. PubMed ID: 18722070
    [Abstract] [Full Text] [Related]

  • 40. Identification of a trace colored impurity in drug substance by preparative liquid chromatography and mass spectrometry.
    Wang P, Shi YJ, Helmy R, Reamer R, Vailaya A.
    Rapid Commun Mass Spectrom; 2005 Nov 04; 19(24):3749-54. PubMed ID: 16308847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.